Register entry
HANDA THERAPEUTICS LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 36
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
36| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11202778 | PHYRAGOdasatinib | use | Jan 2041 |
| 11298356 | PHYRAGOdasatinib | product | Jan 2041 |
| 11324745 | PHYRAGOdasatinib | use | Jan 2041 |
| 12433891 | PHYRAGOdasatinib | use | Jan 2041 |
| 12465606 | PHYRAGOdasatinib | product | Jan 2041 |
| 12544376 | PHYRAGOdasatinib | use | Jan 2041 |
| Product | Exclusivity | Until |
|---|---|---|
| PHYRAGODASATINIB | M-307 Miscellaneous | Dec 2026 |
Enquiry
Common questions
- Is HANDA THERAPEUTICS LLC FDA approved?
- HANDA THERAPEUTICS LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.